Rapid Dose Therapeutics Signs Distribution Agreement for Product Line, Receives US$2.1 Million Purchase Order

Rapid Dose Therapeutics (CSE:DOSE) and Ukraine Pharma announced today that they have signed a twelve month distribution agreement to export QuickStrip™ nutraceutical products to Ukraine and other European countries, giving Rapid Dose Therapeutics the chance to market its products to a consumer base of over 200 million people.

As quoted in the press release:

The Agreement requires a minimum quarterly order of one million of each of RDT’s Energy, B12, and Sleep QuickStrips™ and the Company has provided RDT with a signed purchase order for US$2.1 million.

RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers an Anytime, Anywhere™ product to consumers. Ukraine Pharma expects to distribute QuickStrip™ by the third calendar quarter of 2019.

“This represents the beginning of a growing opportunity for RDT to provide its QuickStrip™ products to people wanting an effective and innovative means of delivering nutraceuticals,” said Mark Upsdell, CEO of RDT. “The Agreement with Ukraine Pharma elevates QuickStrip™ as a growing international brand and delivery device to major market consumers, while simultaneously offering health benefits and improving patient outcomes.”

Click here to read the full press release.